First described in 2001, MuSK antibodies impair agrin-induced AChR clustering during synapse formation and are also present ...

Treatment resistance and relapse in the most common type of lung cancer can be traced to a protein called agrin, according to a preclinical study led by Roswell Park Comprehensive Cancer Center.